Toward Digital Staining using Imaging Mass Spectrometry and Random Forests
- 26 May 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 8 (7), 3558-3567
- https://doi.org/10.1021/pr900253y
Abstract
We show on imaging mass spectrometry (IMS) data that the Random Forest classifier can be used for automated tissue classification and that it results in predictions with high sensitivities and positive predictive values, even when intersample variability is present in the data. We further demonstrate how Markov Random Fields and vector-valued median filtering can be applied to reduce noise effects to further improve the classification results in a posthoc smoothing step. Our study gives clear evidence that digital staining by means of IMS constitutes a promising complement to chemical staining techniques.Keywords
This publication has 42 references indexed in Scilit:
- Molecular imaging of proteins in tissues by mass spectrometryProceedings of the National Academy of Sciences of the United States of America, 2008
- High‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded tissue microarrays using MALDI imaging mass spectrometryProteomics, 2008
- MALDI-FTICR Imaging Mass Spectrometry of Drugs and Metabolites in TissueAnalytical Chemistry, 2008
- Classification of premalignant pancreatic cancer mass-spectrometry data using decision tree ensemblesBMC Bioinformatics, 2008
- Differentiating Proteomic Biomarkers in Breast Cancer by Laser Capture Microdissection and MALDI MSJournal of Proteome Research, 2008
- Breast Cancer Diagnosis from Proteomic Mass Spectrometry Data: A Comparative EvaluationStatistical Applications in Genetics and Molecular Biology, 2008
- Application of the Random Forest Classification Method to Peaks Detected from Mass Spectrometric Proteomic Profiles of Cancer Patients and ControlsStatistical Applications in Genetics and Molecular Biology, 2008
- Mass Spectrometry to Classify Non–Small-Cell Lung Cancer Patients for Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Multicohort Cross-Institutional StudyJNCI Journal of the National Cancer Institute, 2007
- Mechanisms of Indomethacin-Induced Alterations in the Choline Phospholipid Metabolism of Breast Cancer CellsNeoplasia, 2006
- Real‐time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti‐inflammatory agent indomethacinMagnetic Resonance in Medicine, 2002